BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 211 filers reported holding BLUEBIRD BIO INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,048 | -7.6% | 11,200 | 0.0% | 0.00% | – |
Q2 2023 | $36,848 | -52.7% | 11,200 | -54.3% | 0.00% | – |
Q1 2023 | $77,910 | -71.5% | 24,500 | -38.0% | 0.00% | -100.0% |
Q4 2022 | $273,340 | -97.0% | 39,500 | -81.0% | 0.00% | -96.4% |
Q4 2020 | $8,982,000 | +0.9% | 207,564 | +25.8% | 0.03% | -12.5% |
Q3 2020 | $8,904,000 | -45.4% | 165,039 | -38.3% | 0.03% | 0.0% |
Q2 2020 | $16,316,000 | +402.2% | 267,302 | +1191.3% | 0.03% | +166.7% |
Q2 2018 | $3,249,000 | -25.4% | 20,700 | -18.8% | 0.01% | -29.4% |
Q1 2018 | $4,354,000 | -1.8% | 25,500 | +2.4% | 0.02% | 0.0% |
Q4 2017 | $4,435,000 | +193.5% | 24,900 | +126.4% | 0.02% | +142.9% |
Q3 2017 | $1,511,000 | -75.0% | 11,000 | -80.9% | 0.01% | -74.1% |
Q2 2017 | $6,035,000 | -46.4% | 57,447 | -53.6% | 0.03% | -47.1% |
Q1 2017 | $11,259,000 | +39.2% | 123,866 | -5.5% | 0.05% | +34.2% |
Q4 2016 | $8,091,000 | -27.1% | 131,134 | -19.9% | 0.04% | -22.4% |
Q3 2016 | $11,092,000 | +56.7% | 163,651 | +0.1% | 0.05% | +53.1% |
Q2 2016 | $7,080,000 | +11.9% | 163,557 | +9.9% | 0.03% | +14.3% |
Q1 2016 | $6,326,000 | -21.1% | 148,851 | +19.3% | 0.03% | -20.0% |
Q4 2015 | $8,015,000 | -29.9% | 124,798 | -6.7% | 0.04% | -25.5% |
Q3 2015 | $11,440,000 | -18.5% | 133,725 | +60.4% | 0.05% | -16.1% |
Q2 2015 | $14,037,000 | +39.4% | 83,372 | 0.0% | 0.06% | +36.6% |
Q1 2015 | $10,069,000 | +59.2% | 83,372 | +20.9% | 0.04% | +64.0% |
Q4 2014 | $6,323,000 | – | 68,940 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |